Jeffrey S. Aronin


Jeffrey Aronin has nearly 20 years of experience developing global biopharmaceutical companies and innovative solutions to complex human problems. He has spent his career working at the nexus of science, business and social good to provide treatments for some of the world’s most challenging diseases. Aronin’s patient-focused approach and expertise in novel drug development have made him one of the most impactful and successful leaders in the bioscience sector. Driven by his passion for helping patients and by focusing on addressing unmet medical needs, he and his team have received over a dozen novel drug approvals from the FDA, created thousands of jobs, and improved countless lives.


Today, Jeff Aronin is Chairman and Chief Executive Officer of Paragon Biosciences. Paragon’s mission is to improve the lives of patients suffering from debilitating diseases by building innovative biotechnology companies that bring important medicines to the market. This mirrors Aronin’s lifelong commitment to a patient-focused approach to life changing breakthroughs through medical research and entrepreneurship. In addition to leading Paragon, Aronin serves as Chairman of several of Paragon Biosciences’ successful portfolio companies, including Castle Creek Pharmaceuticals, Harmony Biosciences, Emalex Biosciences and Skyline Biosciences.

Previously, Aronin served as President and Chief Executive Officer of Ovation Pharmaceuticals Inc., a biopharmaceutical company he founded in 2000 that was acquired by Lundbeck, Inc. in 2009. He also served as President of Lundbeck, Inc. during its acquisition and integration of Ovation Pharmaceuticals.

Mr. Aronin devotes extensive time to civic and philanthropic endeavors. Chicago Mayor Rahm Emanuel appointed him to the Executive Committee of the Board of Directors of World Business Chicago (WBC), a public-private partnership between the City and Chicago’s business community to spur economic and job growth. Mr. Aronin is also chair of ChicagoNEXT’s bioscience committee, where he spearheaded development of the health-technology startup center MATTER as founder and co-chairman.  At MATTER, Aronin has led one of Chicago’s biggest philanthropic healthcare innovation successes with over 200 companies founded and grown over the past five years. He is also a regular lecturer at the University of Chicago Booth School of Business and Northwestern University Kellogg School of Business.

In addition, Aronin serves on the Board of Directors of Discover Financial Services, Ravinia Music Festival and previously served on the Board of Trustees of Chicago’s Museum of Science and Industry and the University of Chicago Medical Center. He is also a member of the Commercial Club of Chicago.

Aronin is also the recipient of the Weizmann Institute of Science Leadership Award.  Through the Aronin Family foundation, he and his wife Lisa provide funding for patient support, scientific research, and education to build on his commitment to develop innovative solutions to complex human problems.